tiprankstipranks
Trending News
More News >
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
US Market
Advertisement

Interpace Diagnostics Group (IDXG) Ratios

Compare
413 Followers

Interpace Diagnostics Group Ratios

IDXG's free cash flow for Q2 2025 was $0.57. For the 2025 fiscal year, IDXG's free cash flow was decreased by $ and operating cash flow was $-0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.33 0.59 0.85 0.78 0.77
Quick Ratio
1.19 0.52 0.77 0.66 0.66
Cash Ratio
0.07 0.20 0.34 0.21 0.15
Solvency Ratio
0.43 0.06 -0.04 -0.12 -0.28
Operating Cash Flow Ratio
0.71 0.22 -0.54 -0.56 -0.80
Short-Term Operating Cash Flow Coverage
2.85 0.74 -3.08 0.00 0.00
Net Current Asset Value
$ -4.04M$ -17.84M$ -66.90M$ -68.68M$ -60.64M
Leverage Ratios
Debt-to-Assets Ratio
0.26 0.86 1.01 0.36 0.10
Debt-to-Equity Ratio
-2.60 -0.74 -0.26 -0.32 -0.16
Debt-to-Capital Ratio
1.63 -2.84 -0.34 -0.48 -0.19
Long-Term Debt-to-Capital Ratio
0.00 -0.39 -0.22 -0.29 0.00
Financial Leverage Ratio
-10.17 -0.86 -0.25 -0.91 -1.57
Debt Service Coverage Ratio
2.98 0.63 -0.65 -0.72 -36.70
Interest Coverage Ratio
16.55 2.78 -3.81 -12.76 -48.37
Debt to Market Cap
0.49 2.00 3.10 0.31 0.00
Interest Debt Per Share
0.80 2.83 4.03 3.54 1.31
Net Debt to EBITDA
0.41 2.01 -4.97 -7.83 -0.10
Profitability Margins
Gross Profit Margin
64.09%59.44%57.26%43.44%33.10%
EBIT Margin
12.91%6.99%-15.16%-16.22%-79.01%
EBITDA Margin
14.42%9.54%-7.12%-3.21%-62.03%
Operating Profit Margin
13.97%6.97%-12.06%-28.41%-81.96%
Pretax Profit Margin
12.07%2.81%-18.33%-37.31%-80.71%
Net Profit Margin
11.42%1.99%-18.42%-35.69%-80.87%
Continuous Operations Profit Margin
12.04%2.77%-18.42%-17.03%-80.87%
Net Income Per EBT
94.63%71.04%100.50%95.67%100.20%
EBT Per EBIT
86.35%40.26%151.98%131.32%98.47%
Return on Assets (ROA)
41.99%6.16%-36.70%-38.37%-57.36%
Return on Equity (ROE)
-136.67%-5.30%9.30%34.76%90.09%
Return on Capital Employed (ROCE)
122.21%-62.97%-226.42%-51.60%-96.75%
Return on Invested Capital (ROIC)
84.16%269.70%-80.84%-47.77%-92.87%
Return on Tangible Assets
41.99%6.16%-38.79%-64.94%-101.17%
Earnings Yield
141.93%17.20%-133.07%-47.74%-207.11%
Efficiency Ratios
Receivables Turnover
6.27 8.07 6.33 8.84 4.04
Payables Turnover
13.03 10.56 12.96 17.01 4.80
Inventory Turnover
16.74 13.29 11.12 13.08 10.56
Fixed Asset Turnover
16.28 15.15 10.91 3.98 2.76
Asset Turnover
3.68 3.09 1.99 1.08 0.71
Working Capital Turnover Ratio
17.02 -8.67 -11.28 -10.83 -12.86
Cash Conversion Cycle
51.98 38.13 62.36 47.71 49.03
Days of Sales Outstanding
58.19 45.23 57.69 41.28 90.44
Days of Inventory Outstanding
21.80 27.46 32.83 27.90 34.56
Days of Payables Outstanding
28.01 34.55 28.17 21.46 75.97
Operating Cycle
79.99 72.69 90.52 69.17 125.00
Cash Flow Ratios
Operating Cash Flow Per Share
1.14 0.88 -1.82 -2.11 -3.62
Free Cash Flow Per Share
0.95 0.77 -1.89 -2.19 -4.01
CapEx Per Share
0.19 0.11 0.08 0.09 0.39
Free Cash Flow to Operating Cash Flow
0.83 0.88 1.04 1.04 1.11
Dividend Paid and CapEx Coverage Ratio
5.93 8.06 -23.89 -24.63 -9.26
Capital Expenditure Coverage Ratio
5.93 8.06 -23.89 -24.63 -9.26
Operating Cash Flow Coverage Ratio
1.60 0.34 -0.48 -0.64 -3.07
Operating Cash Flow to Sales Ratio
0.11 0.09 -0.24 -0.21 -0.45
Free Cash Flow Yield
115.18%71.19%-181.83%-29.37%-127.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.70 5.81 -0.75 -2.09 -0.48
Price-to-Sales (P/S) Ratio
0.08 0.12 0.14 0.75 0.39
Price-to-Book (P/B) Ratio
-3.01 -0.31 -0.07 -0.73 -0.43
Price-to-Free Cash Flow (P/FCF) Ratio
0.87 1.40 -0.55 -3.40 -0.78
Price-to-Operating Cash Flow Ratio
0.72 1.23 -0.57 -3.54 -0.87
Price-to-Earnings Growth (PEG) Ratio
-0.02 -0.05 0.01 0.05 0.06
Price-to-Fair Value
-3.01 -0.31 -0.07 -0.73 -0.43
Enterprise Value Multiple
0.96 3.22 -6.91 -31.09 -0.73
Enterprise Value
6.30M 12.36M 15.67M 41.29M 14.62M
EV to EBITDA
0.96 3.22 -6.91 -31.09 -0.73
EV to Sales
0.14 0.31 0.49 1.00 0.45
EV to Free Cash Flow
1.50 3.72 -1.96 -4.55 -0.91
EV to Operating Cash Flow
1.25 3.26 -2.04 -4.74 -1.00
Tangible Book Value Per Share
-0.27 -3.51 -15.09 -14.06 -12.13
Shareholders’ Equity Per Share
-0.27 -3.51 -14.88 -10.26 -7.22
Tax and Other Ratios
Effective Tax Rate
0.02 0.02 >-0.01 0.04 >-0.01
Revenue Per Share
10.26 9.32 7.51 9.99 8.04
Net Income Per Share
1.17 0.19 -1.38 -3.57 -6.50
Tax Burden
0.95 0.71 1.00 0.96 1.00
Interest Burden
0.93 0.40 1.21 2.30 1.02
Research & Development to Revenue
0.02 0.02 0.02 0.05 0.09
SG&A to Revenue
0.23 0.23 0.34 0.33 0.64
Stock-Based Compensation to Revenue
<0.01 0.02 0.04 0.03 0.07
Income Quality
0.98 4.72 0.35 0.58 0.55
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis